His main research concerns Molecular biology, Cell biology, Protein kinase A, Biochemistry and cGMP-dependent protein kinase. His Molecular biology research incorporates elements of Transactivation, Mitogen-activated protein kinase kinase, MAP2K7, Lymphocyte and MAP kinase kinase kinase. The study incorporates disciplines such as Transcription, Transfection and Cytoskeleton in addition to Cell biology.
His Protein kinase A study incorporates themes from Serum Response Element, Rho-associated protein kinase and Kinase activity. As part of his studies on Biochemistry, Gerry R. Boss frequently links adjacent subjects like Sulfide. He studied cGMP-dependent protein kinase and Proto-oncogene tyrosine-protein kinase Src that intersect with Tyrosine kinase, Hormone receptor, Thyroid hormone receptor beta and Thyroid hormone receptor alpha.
Gerry R. Boss focuses on Biochemistry, Cyanide, Molecular biology, Cell biology and Cyanide poisoning. He combines subjects such as Antidote, Toxicity, Sodium thiosulfate, Chromatography and Pharmacology with his study of Cyanide. His Pharmacology research includes elements of Vitamin B12 and In vivo.
His work deals with themes such as Cell culture, Protein kinase A, Signal transduction, Regulation of gene expression and 5'-nucleotidase, which intersect with Molecular biology. CGMP-dependent protein kinase is the focus of his Protein kinase A research. His research integrates issues of Smoke inhalation, Anesthesia and Sodium in his study of Cyanide poisoning.
The scientist’s investigation covers issues in Cyanide, Pharmacology, Toxicity, Cyanide poisoning and Anesthesia. His studies deal with areas such as Sodium thiosulfate, Biochemistry, Detoxification and Excipient as well as Cyanide. His Biochemistry study frequently involves adjacent topics like Case-control study.
His Pharmacology research integrates issues from Antidote, Vitamin B12, Cisplatin, Sulfide and Rabbit model. Gerry R. Boss has researched Toxicity in several fields, including Household chemicals, Potassium cyanide and Bioavailability. His research in Cyanide poisoning intersects with topics in Toxicodynamics, CYANIDE EXPOSURE and Intensive care medicine.
His primary areas of investigation include Cyanide, Cyanide poisoning, Toxicity, Anesthesia and Pharmacology. His work in the fields of Cyanide, such as Sodium cyanide, intersects with other areas such as CYANIDE ANTIDOTES. The Cyanide poisoning study combines topics in areas such as Toxicodynamics, CYANIDE EXPOSURE and Intensive care medicine.
His Toxicity study combines topics in areas such as Sulfide and Household chemicals. His study in the fields of Saline, Capnography and Apnea under the domain of Anesthesia overlaps with other disciplines such as Sodium hydrosulfide. The Drug research he does as part of his general Pharmacology study is frequently linked to other disciplines of science, such as Weight loss, therefore creating a link between diverse domains of science.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Proliferation of human malignant astrocytomas is dependent on Ras activation.
Abhijit Guha;Abhijit Guha;Matthias M Feldkamp;Nelson Lau;Gerry Boss.
Oncogene (1997)
Age-Related Physiological Changes and Their Clinical Significance
G R Boss;J E Seegmiller.
Western Journal of Medicine (1981)
Hyperuricemia and gout. Classification, complications and management.
G R Boss;J E Seegmiller.
The New England Journal of Medicine (1979)
Acquired C1 esterase inhibitor deficiency and angioedema: a review.
J A Gelfand;G R Boss;C L Conley;R Reinhart.
Medicine (1979)
Ras activation in human breast cancer
Friederike C. von Lintig;Anna D. Dreilinger;Nissi M. Varki;Anne M. Wallace.
Breast Cancer Research and Treatment (2000)
Nitric oxide and cGMP analogs activate transcription from AP-1-responsive promoters in mammalian cells.
R B Pilz;M Suhasini;S Idriss;J L Meinkoth.
The FASEB Journal (1995)
RAS-GTP LEVELS ARE ELEVATED IN HUMAN NF1 PERIPHERAL NERVE TUMORS
Guha A;Lau N;Huvar I;Gutmann D.
Oncogene (1996)
Enhanced Tumorigenic Behavior of Glioblastoma Cells Expressing a Truncated Epidermal Growth Factor Receptor Is Mediated through the Ras-Shc-Grb2 Pathway
S. A. Prigent;M. Nagane;H. Lin;H. Lin;I. Huvar.
Journal of Biological Chemistry (1996)
Regulation of Gene Expression by cGMP-dependent Protein Kinase TRANSACTIVATION OF THE c-fos PROMOTER
Tanima Gudi;Ivana Huvar;Matthias Meinecke;Suzanne M. Lohmann.
Journal of Biological Chemistry (1996)
Rheb is in a high activation state and inhibits B-Raf kinase in mammalian cells.
Edward Im;Friederike C von Lintig;Jeffrey Chen;Shunhui Zhuang.
Oncogene (2002)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Brigham and Women's Hospital
University of Utah
Beth Israel Deaconess Medical Center
The University of Texas at Arlington
University of Toronto
Oklahoma Medical Research Foundation
City University of Hong Kong
University of Illinois at Urbana-Champaign
University of California, San Diego
University of California, San Diego
Google (United States)
University of Augsburg
Georgia Institute of Technology
Grenoble Alpes University
Princeton University
Swinburne University of Technology
Spanish National Research Council
Newcastle University
Nagoya University
Aarhus University
European University of Brittany
Roswell Park Cancer Institute
Duke University
Yeshiva University
University of Maryland, College Park
Pennsylvania State University